Glympse Bio Company

Glympse Bio develops a powerful new paradigm in diagnostics to enable noninvasive and predictive monitoring of multiple human diseases. The company’s technology uses precisely engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis.Glympse Bio - Crunchbase Company Profile & Fundingwww.crunchbase.com/organization/glympse-bioWas this helpful?

Last Funding Type: Venture - Series Unknown
Headquarters: Cambridge, Massachusetts, United States
Founded Date: 2015-01-01
Last Funding Date: 2021-12-17
Total Funding: 93299987.0
Technology: ['BioTech & HealthTech']
Estimated Revenue: $1M to $10M
Investors Number: 17.0
Industry: Medical BioTech